MGI, a leading life science technology company, has announced a strategic collaboration with Prepaire Labs at MEDLAB Middle East 2024, with a focus on advancing precision medicine. The collaboration includes MGI’s initial corporate order of the groundbreaking DNBSEQ-T20×2 (“T20”) ultra-high throughput sequencer in the Middle East. This marks a significant milestone as it represents the first deployment of MGI’s cutting-edge sequencing technology in drug discovery within the region.
The DNBSEQ-T20×2, powered by MGI’s proprietary DNBSEQTM technology, is a fully automated genetic sequencer that has garnered global attention for its technological breakthroughs, particularly in significantly reducing genome sequencing costs to below $100 per genome. It is designed to address the most demanding sequencing scenarios, covering a wide range of high-throughput sequencing needs in scientific research and clinical applications, including whole-genome sequencing, single-cell sequencing, and more.
The collaboration between MGI and Prepaire Labs aims to achieve several key objectives, including the development of assays for whole-genome sequencing, the creation of a 100% automated smart laboratory, innovation in sequencing methods for complex genome analysis, and co-marketing efforts to enhance scientific collaboration. Prepaire Labs, founded in 2020 and based in Abu Dhabi, is dedicated to revolutionizing drug discovery and precision medicine.
The incorporation of the DNBSEQ-T20×2 into Prepaire Labs’ infrastructure will empower the company with adaptable genome sequencing services, reinforcing the capabilities of its Biotune platform. This platform is designed to offer cost-effective and personalized healthcare solutions. The collaboration signifies a joint commitment to advancing genomic sequencing applications in clinical settings.
MGI’s comprehensive range of products, including the DNBSEQ-T20×2 and the state-of-the-art ZOID-ILR Laboratory Robot, will be showcased at MEDLAB Middle East 2024 in Dubai, providing attendees with the opportunity to explore the latest advancements in life science technology. The collaboration between MGI and Prepaire Labs represents a significant step forward in bringing advanced genomic sequencing capabilities closer to clinical applications and furthering the integration of precision medicine in the Middle East.